Viemed Healthcare (VMD) Income from Continuing Operations (2018 - 2026)
Viemed Healthcare (VMD) posted Income from Continuing Operations of 2713000.0 for Q1 2026, down 53.35% on a QoQ basis from 5816000.0 in Q4 2025, and little changed year-over-year from 2710000.0 in Q1 2025.
Viemed Healthcare (VMD) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Viemed Healthcare's Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 2713000.0 for Q1 2026.
- Quarterly Income from Continuing Operations changed 0.11% year-over-year to 2713000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15379000.0 (up 22.87% YoY) and the FY2025 annual result came in at 15376000.0, up 34.77% from the prior year.
- Income from Continuing Operations was 2713000.0 for Q1 2026 at Viemed Healthcare, down from 5816000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 5816000.0 in Q4 2025 and bottomed at 967000.0 in Q2 2022.
- A 5-year average of 2703705.88 and a median of 2710000.0 in 2025 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 41.03% — and 2023, when it surged 176.68%.
- Viemed Healthcare's Income from Continuing Operations stood at 2438000.0 in 2022, then surged by 42.62% to 3477000.0 in 2023, then climbed by 27.24% to 4424000.0 in 2024, then surged by 31.46% to 5816000.0 in 2025, then plunged by 53.35% to 2713000.0 in 2026.
- Business Quant data shows VMD's Income from Continuing Operations at 2713000.0 in Q1 2026, 5816000.0 in Q4 2025, and 3600000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Viemed Healthcare | 448.46 Mn | 440.63 Mn | 42.83 Mn | 2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.71 Mn |
| Dec 31, 2025 | 5.82 Mn |
| Sep 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 3.25 Mn |
| Mar 31, 2025 | 2.71 Mn |
| Dec 31, 2024 | 4.42 Mn |
| Sep 30, 2024 | 3.91 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 3.48 Mn |
| Sep 30, 2023 | 2.92 Mn |
| Jun 30, 2023 | 2.33 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 2.44 Mn |
| Sep 30, 2022 | 1.06 Mn |
| Jun 30, 2022 | 967,000.00 |
| Mar 31, 2022 | 1.76 Mn |
| Dec 31, 2021 | 4.09 Mn |
| Sep 30, 2021 | 1.79 Mn |
| Jun 30, 2021 | 1.57 Mn |